A Phase 3 interventional study of Supervised Treadmill Exercise and Home-Based Exercise in Peripheral Arterial Disease, Aging and Peripheral Vascular Diseases, sponsored by Northwestern University. Recruiting at 3 sites in United States. Open to participants aged 50 Years and older. Per ClinicalTrials.gov, last updated 2026-04-15.
Sponsored by Northwestern University · Phase 3, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 26 studies in Peripheral Arterial Disease by Northwestern University — 8 open to participants now, 10 under way, 4 of them phase 3. Peripheral Arterial Disease · Northwestern University.
Among the 26 studies in Peripheral Arterial Disease by Northwestern University, this one is the 6th largest by planned enrollment of the 24 interventional ones that give a count, is one of 2 that started in 2023, is one of 7 in phase 3, and was the 20th registered.
1,378 studies on the registry are indexed under Peripheral Arterial Disease; 276 are open to participants now.
Browse Peripheral Arterial Disease studies →8 of the 26 studies in Peripheral Arterial Disease by Northwestern University are open now, in 1 country. Recruiting first, the newest first:
Northwestern University · Sites in United States
Ages 18+
Northwestern University · Sites in United States
Ages 50+
Northwestern University · Sites in United States
Ages 50+
Northwestern University · Sites in United States
Ages 50+
Northwestern University · Sites in United States
Ages 50+
By country, each count listing its studies:
Of the 193 Peripheral Arterial Disease studies recruiting now, 139 (72%) set no upper age limit and 9 (5%) stop at 75 or younger; 13 take children under 18; 19 take healthy volunteers.
This study: 50 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
26 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 5 · Phase 3 7
First in 2007; this study’s year is marked. 2 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 210 is above the median of 70 across 927 interventional studies indexed under Peripheral Arterial Disease.
Median enrollment 192 across the 24 interventional studies, 557 across the 2 observational. Of the 16 that completed or were terminated, 10 (63%) have results posted.
This tab as a report to print or save as PDF → With an account.
Northwestern University is the lead sponsor of 1,424 studies on the registry; 199 are open to participants now.
Of its 105 completed or terminated interventional studies of FDA-regulated products, 78 (74%) have results posted.
3 of the studies in Peripheral Arterial Disease by Northwestern University that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04794530Phase 3Northwestern UniversityThe COCOA-PAD II Trial | 2026-12-31 |
| NCT06399809Northwestern UniversityFisetin to Reduce Senescence and Mobility Impairment in PAD | 2027-06-30 |
| NCT04228978Northwestern UniversityPromote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss | 2027-06-30 |
Add all 3 to your calendar (.ics) → With an account.
Among the 26 studies in Peripheral Arterial Disease by Northwestern University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Supervised exercise therapy (SET), consisting of treadmill exercise conducted three times weekly at a center while supervised by healthcare personnel, is first line therapy for people disabled by lower extremity peripheral artery disease (PAD). However, travelling three times/week to a center for SET is burdensome. Compared to SET, home-based exercise is more accessible and less burdensome. Yet, evidence-based guidelines recommend SET over home-based exercise for PAD. Walking exercise is first line therapy to improve walking distance for PAD, but it does not eliminate ischemic leg symptoms in most people with PAD. The investigators' work and that of others showed that nitrate-rich beetroot juice, which increases plasma nitrite, limb perfusion, and skeletal muscle function, significantly improved exercise tolerance and reduced non-response to exercise in people with and without PAD. The investigators will use a 2 x 2 factorial design to address two major barriers to achieving benefits from exercise therapy for PAD: First, guideline recommendations for supervised exercise therapy (SET) as first line therapy for PAD. Second, the inability of exercise therapy to eliminate PAD-related disability in most people with PAD. Participants will be randomized to one of four groups for 12 weeks: Supervised treadmill exercise + nitrate rich beetroot juice; supervised treadmill exercise + placebo, home-based walking exercise + nitrate rich beetroot juice, home-based walking exercise + placebo.
Supervised exercise therapy (SET), consisting of treadmill exercise conducted three times weekly at a center while supervised by healthcare personnel, is first line therapy for people disabled by lower extremity peripheral artery disease (PAD). However, travelling three times/week to a center for SET is burdensome. As of 2018, only 1.3% of patients with Medicare and symptomatic PAD had enrolled in SET. Compared to SET, home-based exercise is more accessible and less burdensome. Yet, evidence-based guidelines recommend SET over home-based exercise for PAD. In 2021, the investigators reported that a home-based exercise intervention that incorporated behavioral methods significantly improved six-minute walk in PAD, compared to an attention control group. But no randomized trials have compared SET to a home-based exercise intervention that incorporated behavioral change methods in PAD. However, 45% of people with PAD do not meaningfully respond to exercise interventions, defined as failure to improve six-minute walk by > 20 meters. This phenomenon occurs for both supervised and home-based exercise. The investigators' work and that of others showed that nitrate-rich beetroot juice, which increases plasma nitrite, limb perfusion, and skeletal muscle function, significantly improved exercise tolerance and reduced non-response to exercise in people with and without PAD. Therefore, the investigators will use a 2 x 2 factorial design to address two major barriers to achieving benefits from exercise therapy for PAD: First, guideline recommendations for supervised exercise therapy (SET) as first line therapy for PAD. Second, the inability of exercise therapy to eliminate PAD-related disability in most people with PAD. In this 2 x 2 factorial design, participants will be randomized to one of four groups for 12 weeks: Supervised treadmill exercise + nitrate rich beetroot juice; supervised treadmill exercise + placebo, home-based walking exercise + nitrate rich beetroot juice, home-based walking exercise + placebo.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
First, all participants will be age 50 and older. Second, all participants will have PAD. PAD will be defined as either:
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
GFR (glomerular filtration rate) is how much blood the kidneys filter each minute. It is usually estimated from a blood test — eGFR, by formulas such as CKD-EPI or MDRD — and some studies ask for it to be measured directly instead. Usually given in mL/min/1.73 m².
Check the method, the units and the minimum the study states. A value of 90 or above is in the normal-or-high range, but kidney damage can show in other tests too.
Life expectancy
The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
GFR and eGFR (kidney filtering)
GFR (glomerular filtration rate) is how much blood the kidneys filter each minute. It is usually estimated from a blood test — eGFR, by formulas such as CKD-EPI or MDRD — and some studies ask for it to be measured directly instead. Usually given in mL/min/1.73 m².
Check the method, the units and the minimum the study states. A value of 90 or above is in the normal-or-high range, but kidney damage can show in other tests too.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
This group will be participating in Supervised Treadmill Exercise and drinking nitrate rich beetroot juice for 12 weeks.
Behavioral: Supervised Treadmill Exercise · Dietary Supplement: Nitrate-rich beetroot Juice
This group will be participating in Supervised Treadmill Exercise and drinking placebo beetroot juice with nitrate removed for 12 weeks.
Behavioral: Supervised Treadmill Exercise
This group will be participating in Home-Based Exercise and drinking nitrate rich beetroot juice for 12 weeks.
Behavioral: Home-Based Exercise · Dietary Supplement: Nitrate-rich beetroot Juice
This group will be participating in Home-Based Exercise and drinking placebo beetroot juice with nitrated removed for 12 weeks.
Behavioral: Home-Based Exercise
This is a 12 week intervention where participants will walk for exercise 3 times a week on a treadmill at a center while being supervised by healthcare personnel.
This is a 12 week intervention where participants will walk at home for exercise with guidance from a study coach. They will have 4 in person visits in the first four weeks and then have weekly phone calls in the last 8 weeks of the intervention with their coach.
Participants will drink one shot of nitrate rich beet-root juice twice daily for 12 weeks.
Six-Minute Walk Distance
Change in six-minute walk distance
Time frame: Measured at baseline and 12 week follow-up
Walking Impairment Questionnaire (WIQ) Distance Score
WIQ distance score - Range 0-100, 100 is best.
Time frame: measured at baseline and 12 weeks
PROMIS Mobility Questionnaire Score
PROMIS mobility score from administered PROMIS questionnaire. Score range is from zero to infinity and a higher score means a better outcome.
Time frame: measured at baseline and 12 weeks
20-meter Improvement in Six-Minute Walk Distance
Meaningful response to exercise interventions
Time frame: measured at 12 weeks
Step Count
Step count measured over seven days with the FITBIT
Time frame: measured at baseline and 12 weeks
Six-Minute Walk Distance
Change in six-minute walk distance
Time frame: Measured at baseline and 24-week follow up
Physical Activity Step Count
Step count measured over seven days with FITBIT
Time frame: Measured at baseline and 24 weeks
Physical activity distance
Physical activity distance measured over seven days with FITBIT
Time frame: Measured at baseline and 24 weeks.
Short physical performance battery (SPPB)
SPPB range, range 0-12, 12-best
Time frame: measured at baseline and 12 weeks
Walking Impairment Questionnaire (WIQ) Stair Climbing Score
WIQ stair climbing score from administered WIQ, range 0-100, 100 is best.
Time frame: measured at baseline and 12 weeks
Walking Impairment Questionnaire (WIQ) Walking Speed Score
WIQ walking speed score from administered WIQ, range 0-100, 100 is best
Time frame: measured at baseline and 12 weeks
Walking Impairment Questionnaire (WIQ) Stair Climbing Score
WIQ stair climbing score from administered WIQ, range 0-100, 100 is best
Time frame: measured at baseline and 24 weeks
Walking Impairment Questionnaire (WIQ) Walking Speed Score
WIQ walking speed score from administered WIQ, range 0-100, 100 is best
Time frame: measured at baseline and 24 weeks
Short physical performance battery (SPPB)
SPPB range, range 0-12, 12-best
Time frame: measured at baseline and 24 weeks
Physical Activity Total Distance
Distance walked over seven days measured with FITBIT
Time frame: Measured at baseline and 12 weeks
Started Sep 2023 (actual). Primary completion is estimated for Nov 2028, 61 months after the start.
Of 26 phase 3 interventional studies under Peripheral Arterial Disease, half reached primary completion within 51 months of starting (the median), counting those still running; a quarter within 37 and three quarters within 58. This study's planned 61 months is above that.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.